Pfizer Inc.
PFENYSEHealthcare● Active
$26.04
+$0.35(+1.34%)
Market Cap$148.4B
P/E Ratio—
52W High$28.75
52W Low$23.08
Pfizer Inc. (PFE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PFE · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $62.58B | $63.63B | $59.55B | $100.33B | $81.29B |
| Cost of Revenue | $18.57B | $21.78B | $29.21B | $38.24B | $34.41B |
| Gross Profit | $44.01B | $41.85B | $30.34B | $62.09B | $46.88B |
| Gross Margin %(computed) | 70.33% | 65.77% | 50.95% | 61.89% | 57.67% |
| Operating Expenses | |||||
| R&D Expenses | $11.98B | $10.74B | $10.58B | $11.43B | $13.83B |
| G&A Expenses | $0.00B | $11.47B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $28.58B | $25.36B | $25.05B | $24.54B | $26.08B |
| Operating Income | $15.44B | $16.48B | $5.29B | $37.55B | $20.79B |
| Operating Margin %(computed) | 24.67% | 25.91% | 8.89% | 37.43% | 25.58% |
| Interest Income | $0.60B | $0.55B | $1.62B | $0.25B | $0.04B |
| Interest Expense | $2.67B | $3.09B | $2.21B | $1.24B | $1.29B |
| Income Before Tax | $7.52B | $8.02B | $1.06B | $34.73B | $24.31B |
| Income Tax Expense | ($0.27B) | ($0.03B) | ($1.11B) | $3.33B | $1.85B |
| Net Income | $7.77B | $8.02B | $2.13B | $31.36B | $22.15B |
| Net Margin %(computed) | 12.42% | 12.60% | 3.58% | 31.26% | 27.25% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.36 | $1.42 | $0.38 | $5.59 | $3.95 |
| Wtd Avg Shares | 5.68B | 5.66B | 5.64B | 5.61B | 5.60B |
| EBITDA | $15.10B | $18.13B | $9.56B | $41.03B | $30.79B |
| EBITDA Margin %(computed) | 24.12% | 28.49% | 16.05% | 40.90% | 37.88% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Pfizer Inc. data
About Pfizer Inc. (PFE) Income Statement
Pfizer Inc. (PFE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PFE reported revenue of $62.58B, gross profit of $44.01B (gross margin 70.33%), and net income of $7.77B — a net profit margin of 12.42%.
Frequently asked questions
PFE · 4 questionsPfizer Inc. (PFE) reported revenue of $62.58B for 2025, down 1.6% year-over-year.
PFE revenuePFE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08